Generic Ornova 20mg contains Vonoprazan 20mg, a potassium competitive acid blocker (P-CAB) used for acid-related disorders.

Description: Ornova 20mg is an oral tablet formulated with Vonoprazan, a fast-acting and long-lasting acid suppressant. It treats gastric and duodenal ulcers, reflux esophagitis, and Helicobacter pylori eradication therapy.

Benefits: Ornova 20mg effectively relieves gastric acid-related disorders by blocking acid production at the source. It ensures sustained suppression of stomach acid, reducing ulcer formation and reflux symptoms. It also supports Helicobacter pylori eradication therapy when combined with antibiotics.

Ingredients Each tablet of Ornova 20mg contains Vonoprazan 20mg as the active ingredient, along with excipients for stability and absorption enhancement.

Uses and Doses For gastric ulcer and duodenal ulcer, the standard dose is 20mg once daily for 8 weeks (gastric ulcer) and 6 weeks (duodenal ulcer). For reflux esophagitis, 20mg is taken once daily for 4 weeks, extendable up to 8 weeks if needed. Maintenance therapy for recurrent esophagitis requires 10mg once daily, with an increase to 20mg if necessary. For Helicobacter pylori eradication, 20mg of Ornova is taken twice daily along with amoxicillin and clarithromycin for 7 days. If initial eradication fails, metronidazole replaces clarithromycin in the regimen.

Side Effects Common side effects include diarrhea, constipation, nausea, abdominal bloating, and rash. Rare but serious side effects include hepatotoxicity, hypersensitivity reactions, jaundice, and abnormal liver function test results.

How to Use Ornova 20mg can be taken at any time of the day, with or without food. It should be swallowed whole with water and not chewed or crushed.

Pregnancy & Lactation Ornova should be used in pregnancy only if the benefits outweigh the potential risks. It is advised to avoid administration in breastfeeding mothers unless deemed essential by a healthcare provider.

Precautions and Warnings Long-term use should be monitored via endoscopy to check for disease progression. Maintenance therapy may reduce or discontinue the dose when symptoms are well controlled. Use with caution in elderly patients and those with hepatic or renal impairment. Avoid in patients receiving atazanavir, nelfinavir, or rilpivirine.

Safety Information: Ensure usage under medical supervision. Not recommended for pediatric patients. Patients should report any severe allergic reactions or worsening symptoms to a doctor immediately.

Indications Ornova 20mg is indicated for gastric and duodenal ulcers, reflux esophagitis, prevention of ulcer recurrence in aspirin or NSAID users, and Helicobacter pylori eradication therapy.

Pharmacology Vonoprazan is a potassium competitive acid blocker that inhibits gastric acid production by reversibly blocking H+, K+-ATPaser. It maintains high potency and long-lasting suppression of acid secretion, ensuring adequate mucosal protection.

Therapeutic Class Potassium competitive acid blocker.

Storage Conditions Store below 30°C in a cool, dry place, away from light. Keep out of reach of children.

3 FAQ

1. Can Ornova 20mg be taken with food? Yes, it can be taken with or without food.
2. How long does Ornova take to work? Symptom relief can begin within a few hours, with full effect achieved over days of regular use.
3. Can Ornova be used long-term? Yes, but long-term therapy should be monitored to assess risks and benefits.

Disclaimer: This information is for educational purposes only and should not replace medical advice. Consult a doctor before using Ornova 20mg.

Keywords: Gastric ulcer treatment, duodenal ulcer, reflux esophagitis, Vonoprazan tablet, acid blocker, stomach acid relief, H. pylori eradication, gastro medicine, ACI Limited, digestive health, gastric protection, acid reflux management, ulcer prevention, P-CAB therapy, acid secretion control, long-acting acid blocker, gastrointestinal care, prescription medicine, stomach health, ulcer management.